share_log

奥本海默:维持Tarsus Pharmaceuticals(TARS.US)评级,由优于大市调整至优于大市评级, 目标价由59.00美元调整至61.00美元。

Zhitong Finance ·  May 9 13:04

奥本海默:维持Tarsus Pharmaceuticals(TARS.US)评级,由优于大市调整至优于大市评级, 目标价由59.00美元调整至61.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment